ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/02/10 | 2,850 | 2,890 | 2,830 | 2,885 | +70 | +2.5% | 826,400 |
2017/02/09 | 2,805 | 2,840 | 2,805 | 2,815 | -15 | -0.5% | 469,000 |
2017/02/08 | 2,825 | 2,840 | 2,800 | 2,830 | +5 | +0.2% | 519,600 |
2017/02/07 | 2,820 | 2,845 | 2,800 | 2,825 | ±0 | ±0% | 547,600 |
2017/02/06 | 2,875 | 2,875 | 2,800 | 2,825 | -25 | -0.9% | 646,000 |
2017/02/03 | 2,880 | 2,910 | 2,840 | 2,850 | -30 | -1% | 746,800 |
2017/02/02 | 2,850 | 2,925 | 2,835 | 2,880 | +40 | +1.4% | 1,092,400 |
2017/02/01 | 2,815 | 2,850 | 2,795 | 2,840 | +40 | +1.4% | 879,000 |
2017/01/31 | 2,835 | 2,845 | 2,790 | 2,800 | -45 | -1.6% | 825,000 |
2017/01/30 | 2,855 | 2,870 | 2,795 | 2,845 | -25 | -0.9% | 1,756,800 |
2017/01/27 | 2,925 | 2,925 | 2,845 | 2,870 | -45 | -1.5% | 1,021,400 |
2017/01/26 | 2,900 | 2,925 | 2,880 | 2,915 | +45 | +1.6% | 876,200 |
2017/01/25 | 2,885 | 2,905 | 2,845 | 2,870 | +20 | +0.7% | 887,600 |
2017/01/24 | 2,845 | 2,890 | 2,835 | 2,850 | -25 | -0.9% | 874,200 |
2017/01/23 | 2,930 | 2,960 | 2,860 | 2,875 | -75 | -2.5% | 945,000 |
2017/01/20 | 2,910 | 2,970 | 2,900 | 2,950 | +40 | +1.4% | 911,400 |
2017/01/19 | 2,935 | 2,975 | 2,900 | 2,910 | -40 | -1.4% | 1,127,000 |
2017/01/18 | 2,990 | 3,000 | 2,930 | 2,950 | -55 | -1.8% | 962,400 |
2017/01/17 | 3,015 | 3,045 | 2,990 | 3,005 | -20 | -0.7% | 812,600 |
2017/01/16 | 3,050 | 3,050 | 3,005 | 3,025 | -20 | -0.7% | 792,400 |
2017/01/13 | 2,985 | 3,060 | 2,980 | 3,045 | +35 | +1.2% | 1,123,600 |
2017/01/12 | 3,050 | 3,065 | 2,995 | 3,010 | -85 | -2.7% | 1,250,400 |
2017/01/11 | 3,150 | 3,150 | 3,060 | 3,095 | -30 | -1% | 1,163,400 |
2017/01/10 | 3,100 | 3,160 | 3,095 | 3,125 | +50 | +1.6% | 1,708,200 |
2017/01/06 | 3,055 | 3,100 | 3,045 | 3,075 | -5 | -0.2% | 1,041,400 |
2017/01/05 | 3,075 | 3,130 | 3,055 | 3,080 | ±0 | ±0% | 1,523,600 |
2017/01/04 | 3,095 | 3,100 | 3,040 | 3,080 | +40 | +1.3% | 1,376,200 |
2016/12/30 | 2,980 | 3,065 | 2,945 | 3,040 | +35 | +1.2% | 1,622,600 |
2016/12/29 | 3,000 | 3,030 | 2,910 | 3,005 | +5 | +0.2% | 2,202,600 |
2016/12/28 | 2,905 | 3,015 | 2,900 | 3,000 | +105 | +3.6% | 2,430,000 |
2016/12/27 | 2,855 | 2,915 | 2,850 | 2,895 | +105 | +3.8% | 2,464,400 |
2016/12/26 | 2,690 | 2,805 | 2,690 | 2,790 | +110 | +4.1% | 1,082,400 |
2016/12/22 | 2,695 | 2,720 | 2,665 | 2,680 | -25 | -0.9% | 666,600 |
2016/12/21 | 2,765 | 2,770 | 2,685 | 2,705 | -90 | -3.2% | 1,493,400 |
2016/12/20 | 2,810 | 2,820 | 2,785 | 2,795 | -35 | -1.2% | 805,200 |
2016/12/19 | 2,800 | 2,840 | 2,765 | 2,830 | +25 | +0.9% | 931,000 |
2016/12/16 | 2,795 | 2,830 | 2,770 | 2,805 | +45 | +1.6% | 1,494,600 |
2016/12/15 | 2,675 | 2,760 | 2,655 | 2,760 | +100 | +3.8% | 1,532,400 |
2016/12/14 | 2,720 | 2,735 | 2,655 | 2,660 | -40 | -1.5% | 962,000 |
2016/12/13 | 2,580 | 2,715 | 2,580 | 2,700 | +80 | +3.1% | 1,409,600 |
2016/12/12 | 2,595 | 2,640 | 2,545 | 2,620 | +75 | +2.9% | 1,169,000 |
2016/12/09 | 2,450 | 2,565 | 2,450 | 2,545 | +45 | +1.8% | 1,443,000 |
2016/12/08 | 2,560 | 2,570 | 2,495 | 2,500 | -85 | -3.3% | 1,722,200 |
2016/12/07 | 2,650 | 2,655 | 2,580 | 2,585 | -95 | -3.5% | 1,314,400 |
2016/12/06 | 2,740 | 2,750 | 2,665 | 2,680 | -60 | -2.2% | 884,600 |
2016/12/05 | 2,730 | 2,770 | 2,720 | 2,740 | +10 | +0.4% | 625,400 |
2016/12/02 | 2,760 | 2,765 | 2,690 | 2,730 | -60 | -2.2% | 1,215,800 |
2016/12/01 | 2,855 | 2,860 | 2,765 | 2,790 | -60 | -2.1% | 1,237,600 |
2016/11/30 | 2,845 | 2,890 | 2,845 | 2,850 | +25 | +0.9% | 1,325,400 |
2016/11/29 | 2,825 | 2,910 | 2,815 | 2,825 | -10 | -0.4% | 1,719,800 |
2001~
2050
件表示中 / 2898件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 189,200円 | +5.0% | +1.5% | 0.00% | 16.24倍 | 4.32倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サワイGHD | 195,500円 | +4.0% | +25.4% | 2.71% | 8.55倍 | 1.12倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
日本新薬 | 358,000円 | +7.9% | +8.9% | 3.46% | 7.66倍 | 1.03倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
科研薬 | 406,100円 | +30.5% | +111.0% | 4.68% | 11.45倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 376,000円 | +14.5% | -2.3% | 2.39% | 13.75倍 | 0.73倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム